These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 2481785

  • 1. Clinical and hemodynamic effects of celiprolol in essential hypertension.
    Parati G, Ravogli A, Bragato R, Omboni S, Mutti E, Mancia G.
    J Cardiovasc Pharmacol; 1989; 14 Suppl 7():S14-21. PubMed ID: 2481785
    [Abstract] [Full Text] [Related]

  • 2. Celiprolol--overview of 6 years of clinical trials experience.
    Pruss TP, Lamon KD, Hagen NS.
    J Int Med Res; 1988; 16 Suppl 1():17A-22A. PubMed ID: 2906015
    [Abstract] [Full Text] [Related]

  • 3. 24-h ambulatory non-invasive blood pressure monitoring in the assessment of the antihypertensive action of celiprolol.
    Parati G, Pomidossi G, Casadei R, Ravogli A, Trazzi S, Mutti E, Mancia G.
    J Int Med Res; 1988; 16 Suppl 1():52A-61A. PubMed ID: 2975612
    [Abstract] [Full Text] [Related]

  • 4. Different hemodynamic effects of celipropol and atenolol in patients with mild to moderate hypertension.
    Saner H, Seiler A, Mahler F.
    Arzneimittelforschung; 1995 Jul; 45(7):790-5. PubMed ID: 8573224
    [Abstract] [Full Text] [Related]

  • 5. Long-term reduction of peripheral resistance with celiprolol and effects on left ventricular mass.
    Trimarco B, Lembo G, DeLuca N, Ricciardelli B, Rosiello G, Volpe M, Orofino G, Condorelli M.
    J Int Med Res; 1988 Jul; 16 Suppl 1():62A-72A. PubMed ID: 2906018
    [Abstract] [Full Text] [Related]

  • 6. Comparison of the antihypertensive effects of celiprolol and enalapril.
    Ghiringhelli S, Cozzi E, Tsialtas D.
    J Int Med Res; 1988 Jul; 16 Suppl 1():73A-79A. PubMed ID: 2906019
    [Abstract] [Full Text] [Related]

  • 7. Bronchosparing properties of celiprolol, a new beta 1, alpha 2-blocker, in propranolol-sensitive asthmatic patients.
    Matthys H, Doshan HD, Rühle KH, Applin WJ, Braig H, Pohl M.
    J Cardiovasc Pharmacol; 1986 Jul; 8 Suppl 4():S40-2. PubMed ID: 2427851
    [Abstract] [Full Text] [Related]

  • 8. Celiprolol and atenolol in angina--effects on left ventricular function.
    Dargie H, McLenachan JM, Wilson JT.
    J Int Med Res; 1988 Jul; 16 Suppl 1():47A-51A. PubMed ID: 2906017
    [Abstract] [Full Text] [Related]

  • 9. Celiprolol, atenolol and propranolol: a comparison of pulmonary effects in asthmatic patients.
    Doshan HD, Rosenthal RR, Brown R, Slutsky A, Applin WJ, Caruso FS.
    J Cardiovasc Pharmacol; 1986 Jul; 8 Suppl 4():S105-8. PubMed ID: 2427836
    [Abstract] [Full Text] [Related]

  • 10. Metoprolol and atenolol administered once daily in primary hypertension. A clinical comparison of the efficacy of two selective beta-adrenoceptor blocking agents.
    Lyngstam O, Rydén L.
    Acta Med Scand; 1981 Jul; 209(4):261-6. PubMed ID: 7015797
    [Abstract] [Full Text] [Related]

  • 11. [Antihypertensive action of various talinolol dosages after four week's treatment in comparison with placebo].
    Weigmann I, Terhaag B, Wierich W, Herrmann WM.
    Arzneimittelforschung; 1998 Mar; 48(3):240-4. PubMed ID: 9553680
    [Abstract] [Full Text] [Related]

  • 12. [Effect of celiprolol compared to propranolol on thyroid metabolism].
    Langsteger W, Lind P, Eber O.
    Wien Med Wochenschr; 1985 Sep 30; 135(18):451-7. PubMed ID: 2865857
    [Abstract] [Full Text] [Related]

  • 13. [Acute changes of coronary and global hemodynamics in patients with angina pectoris and arterial hypertension caused by celiprolol and metoprolol].
    Franz N, Modersohn D, Linss G, Heublein B, Gola G, Bruch L, Walde T.
    Radiol Diagn (Berl); 1990 Sep 30; 31(6):625-8. PubMed ID: 1982742
    [Abstract] [Full Text] [Related]

  • 14. Celiprolol. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in cardiovascular disease.
    Milne RJ, Buckley MM.
    Drugs; 1991 Jun 30; 41(6):941-69. PubMed ID: 1715268
    [Abstract] [Full Text] [Related]

  • 15. Clinical performance and therapeutic potential of celiprolol in angina pectoris.
    Soberman JE, Frishman WH.
    J Cardiovasc Pharmacol; 1989 Jun 30; 14 Suppl 7():S9-13. PubMed ID: 2481791
    [Abstract] [Full Text] [Related]

  • 16. Antihypertensive therapy with celiprolol: a new cardioselective beta blocker.
    Norris RJ.
    Am J Cardiol; 1988 Feb 10; 61(5):14C-22C. PubMed ID: 2893531
    [Abstract] [Full Text] [Related]

  • 17. Randomized controlled trial of ACE-inhibitors and beta-blockers with and without vasodilating activity in chronic glomerulonephritis.
    Erley CM, Klass M, Krämer D, Berger E, Heyne N, Braun N, Wolf S, Risler T.
    Int J Clin Pharmacol Ther; 1996 Nov 10; 34(11):504-9. PubMed ID: 8937934
    [Abstract] [Full Text] [Related]

  • 18. The role of the new beta-blockers in treating cardiovascular disease.
    Weber MA.
    Am J Hypertens; 2005 Dec 10; 18(12 Pt 2):169S-176S. PubMed ID: 16373195
    [Abstract] [Full Text] [Related]

  • 19. Celiprolol. A preliminary review of its pharmacodynamic and pharmacokinetic properties and its therapeutic use in hypertension and angina pectoris.
    Riddell JG, Shanks RG, Brogden RN.
    Drugs; 1987 Oct 10; 34(4):438-58. PubMed ID: 2890513
    [Abstract] [Full Text] [Related]

  • 20. Catecholamines and heart function in heart transplant patients: effects of beta1- versus nonselective beta-blockade.
    Leenen FH, Davies RA, Fourney A.
    Clin Pharmacol Ther; 1998 Nov 10; 64(5):522-35. PubMed ID: 9834044
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.